Track the 엘앤케이바이오 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 엘앤케이바이오 has recorded 59 insider filings. The latest transaction was reported on 27 February 2026 (Other). Among the most active insiders: 강국진. All data is free.
56
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
엘앤케이바이오 operates in the health and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions in the medical field.